Us Signs Contract with Pfizer for Covid-19 Vaccine Doses

On Wednesday, January 27th, the United States government announced that it has inked a deal with Pfizer to acquire an additional 100 million doses of the COVID-19 vaccine. With this new contract, the government is on track to have enough doses to vaccinate all Americans who want to get vaccinated against the novel coronavirus.

The announcement of this deal comes as the Biden administration has promised to ramp up vaccine distribution and administration across the country. This new agreement will bring Pfizer`s total commitment to the United States to 200 million doses. According to the pharmaceutical company, it will deliver the additional doses by the end of July 2021.

The agreement also includes an option to purchase an additional 400 million doses of the vaccine, which could bring the total number of doses supplied by Pfizer to the US government to 600 million. This option is contingent upon Pfizer`s ability to manufacture and deliver the doses in a timely manner.

The Pfizer-BioNTech vaccine was the first COVID-19 vaccine to receive emergency use authorization from the US Food and Drug Administration (FDA) in December 2020. The vaccine has been shown to be highly effective at preventing COVID-19, with a reported efficacy rate of over 90% in clinical trials.

Since the start of the pandemic, the US has been one of the hardest-hit countries, with over 25 million confirmed cases and 430,000 deaths to date. The rollout of the COVID-19 vaccines has been seen as a critical milestone in the fight against the virus, and this new contract with Pfizer is a significant step forward in the country`s vaccination efforts.

It`s important to note that the vaccine distribution process is complex and challenging. The US government must work with state and local authorities to distribute the vaccines to healthcare providers and other frontline workers. As more doses become available, the process will become more streamlined, but it will likely take several months to vaccinate the majority of the population.

The new contract with Pfizer is a positive development in the ongoing battle against COVID-19. As more doses become available and more people get vaccinated, the country will move closer to achieving herd immunity and ending the pandemic once and for all.